Universe Pharmaceuticals (UPC) Total Debt (2021 - 2025)

Universe Pharmaceuticals (UPC) has 5 years of Total Debt data on file, last reported at $7.1 billion in Q3 2025.

• For the quarter ending Q3 2025, Total Debt fell 10.56% year-over-year to $7.1 billion; the trailing twelve-month figure through Sep 2025 stood at $7.1 billion (down 10.56% YoY), and the FY2025 full-year result was $7.1 billion, down 10.56% from the prior year.
• Total Debt slipped to $7.1 billion in Q3 2025, from $8.0 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $8.0 billion in Q3 2024 to a low of $19723.0 in Q3 2021.
• A 5-year average of $2.5 billion and a median of $4.4 million in 2022 frame the typical range for Total Debt.
• Across the five-year window, Total Debt soared 145713.96% in 2024 and retreated 10.56% in 2025, its largest moves.
• Tracing UPC's Total Debt over 5 years: stood at $19723.0 in 2021, then soared by 17033.62% to $3.4 million in 2022, then surged by 62.24% to $5.5 million in 2023, then soared by 145713.96% to $8.0 billion in 2024, then dropped by 10.56% to $7.1 billion in 2025.
• Business Quant data shows UPC's Total Debt at $7.1 billion in Q3 2025, $8.0 billion in Q3 2024, and $2.1 million in Q1 2024.